RLI has gained 8% this week and 13% over the past month, but the stock's first real test arrives today: Q2 results are in, and the analyst community has split sharply on what they mean.
The most consequential move came from Wells Fargo this morning. Analyst Hristian Getsov downgraded RLI to Underweight with a $57 target — below the current $65.10 close — after previously sitting at Equal-Weight with a $62 target. That's a clear call that the post-earnings rally has overshot. On the other side, Keefe, Bruyette & Woods raised its Outperform target to $74 from $70 this morning, keeping its constructive view intact. The consensus remains a Hold, with six analysts at Hold and one at Sell, and no Buy ratings on the board. The split matters: KBW's $74 suggests another 14% of upside; Wells Fargo's $57 target implies the stock is already 12% too expensive.
The positioning picture tells a story of shorts rebuilding ahead of — and through — the number. Short interest has climbed nearly 29% over the past month to 8.3% of the free float, with the bulk of that addition arriving in the last two weeks. Days to cover hit 9.2 on the latest official reading, which means any forced covering takes real time. Despite that, the borrow market remains loose — availability at roughly 296% means there are nearly three shares available to lend for every one already borrowed, so there is no mechanical squeeze pressure. Cost to borrow has drifted higher at 0.60%, up about 22% on the week, but that remains firmly in "easy borrow" territory. The options market, however, flashed something more extreme: the put/call ratio jumped to 6.23 on Tuesday, more than four standard deviations above its 20-day average of 3.29 — the highest single-day reading in months. That spike in put demand arrived the day before earnings and looks like targeted hedging rather than structural pessimism.
The insider buyers who featured in last week's earnings preview note are now sitting on substantial gains. The CEO bought 5,000 shares at $52 in late May. The COO bought twice, the independent chairman once, and a director twice — all between $51 and $53. The stock has since moved to $65, meaning those purchases are up roughly 23–27% in under two months. Their confidence appears vindicated by the immediate post-earnings price action, though the Wells Fargo downgrade this morning suggests some on the Street view the vindication as already priced in.
The factor picture adds one more layer of tension. RLI's earnings surprise rank sits at the 96th percentile — one of the most consistent beat records in the universe — which is a structural bull case. But EPS momentum scores rank in the bottom quartile (23rd percentile on 30-day, 22nd on 90-day), suggesting forward estimates are not moving higher fast enough to sustain momentum-driven flows. Peers had a strong week: ERIE gained 12.3%, KNSL added 9.1%, and ACGL rose 5.9% — all outpacing RLI's 8.1% weekly gain on a risk-adjusted basis given RLI's heavier short interest overhang.
The KBW upgrade and the Wells Fargo downgrade arriving on the same morning, against a backdrop of freshly rebuilt short interest and a one-day options spike, sets up the next few sessions as a referendum on whether the Q2 print justifies the re-rating — or whether the bears who rushed in ahead of earnings were early rather than wrong.
See the live data behind this article on ORTEX.
Open RLI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
